Free Trial

Siemens Healthineers Q2 2023 Earnings Report

Siemens Healthineers logo
$27.06 +0.03 (+0.11%)
(As of 12/20/2024 05:55 PM ET)

Siemens Healthineers EPS Results

Actual EPS
$0.23
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Siemens Healthineers Revenue Results

Actual Revenue
$5.74 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Siemens Healthineers Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

First JFK… next Elon? (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Siemens Healthineers Earnings Headlines

Siemens Healthineers AG (SEMHF) Receives a Buy from Bernstein
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)
Siemens Healthineers Reports Strong Fiscal Year 2024
See More Siemens Healthineers Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Siemens Healthineers? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Siemens Healthineers and other key companies, straight to your email.

About Siemens Healthineers

Siemens Healthineers (OTCMKTS:SMMNY), through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

View Siemens Healthineers Profile

More Earnings Resources from MarketBeat

Upcoming Earnings